Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–49
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Chronically infected with hepatitis C virus genotype 1
Treatment naive or treatment non-responders or treatment intolerant; and not co-infected with HIV or hepatitis B virus
Hepatitis C virus RNA viral load of ≥ 10\*5\* IU/mL
BMI 18 to 35 kg/m²
You may not be if
Any significant acute or chronic medical illness which is not stable or is not controlled with medication and not consistent with hepatitis C virus infection
Major surgery within 4 weeks of study drug administration and any gastrointestinal surgery that could impact the absorption of study drug
Clareo Health | A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects
